Delivery Order SPE2DB22D9316-SPE2DB25FYP74
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29,723.36 on August 18, 2025, for the supply of Isosulfan Blue 1% in 5ml vials. The award, issued by the Defense Logistics Agency under its Medical Supply Chain program, represents a delivery order against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,985.30, is for the delivery of 4563043017 - Isosulfan Blue 1% Vial 5ML, with a period of performance through December 5, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $12,985.30, is for the delivery of 4,563,013,516 vials of 1% Isosulfan Blue, a specialized pharmaceutical product used in medical procedures. The order has an ultimate completion date of December 1, 2023. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML medical supplies, with a ceiling value of $7,430.84 and a period of performance through April 16, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for VisionBlue 0.06% syringes in 0.5mL quantities. This firm fixed-price delivery order, valued at $8,455.80, is scheduled for completion by September 23, 2025, and was awarded on September 2, 2025. The award carries no set-aside designation, allowing the vendor to compete on a competitive basis. DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, covers the supply of VisionBlue 0.06% syringes in 0.5ml units. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,227.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VisionBlue 0.06% syringes in 0.5ML units. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge facility and will...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $3,382.32 delivery order by the Defense Logistics Agency's Medical Supply Chain division on September 8, 2025, for Trypan Blue Ophthalmic products. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and was awarded without set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc. for TISSUEBLUE 0.025% syringe in 0.5mL quantities. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025. No set-aside designation was used for this procurement. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,536.74 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of VisionBlue 0.06% syringes in 0.5ml quantities. The contract operates under a firm fixed-price structure with an ultimate completion date of May 15, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP74Delivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $29,723.36 for Isosulfan Blue 1% vials (5mL) on August 8, 2025. The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of August 11, 2025, and carries no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million single-award vehicle valid through November 2026 that enables the agency to issue delivery orders for an extensive range of pharmaceutical products supporting military health facilities. Isosulfan Blue is a vital diagnostic agent used in surgical procedures for lymph node identification and mapping, making this delivery order essential for supporting Department of Defense medical operations. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts to provide branded and generic prescription drugs, biologics, medical consumables, and specialty medications to military and federal healthcare facilities nationwide. The company's robust portfolio with the DLA demonstrates its capability to efficiently deliver specialized pharmaceutical products directly to DoD healthcare sites globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.7k | 8/8/25 |